We sought to investigate whether there exist ER-α36-EGFR/HER2 regulatory loops in ER-positive breast cancer stem/progenitor cells and disruption of these loops sensitizes these cancer stem/progenitor cells to TAM. The gene discussed is EGFR; the disease is breast carcinoma.